Boehringer Ingelheim is a global pharmaceutical leader with over 53,000 employees dedicated to advancing health through innovation. Specializing in human and animal healthcare, the company offers a range of products including biopharmaceuticals, contract manufacturing, and research services. Committed to improving lives worldwide, Boehringer Ingelheim's collaborative culture drives breakthroughs in pharmaceutical science.
Contribute to execute CDMA (Clinical Development & Medical Affairs) activities in Japan according to TA (Therapeutic Area) strategy between start of preclinical development and late stages of commercialization.
Boehringer Ingelheim is a global pharmaceutical leader with over 53,000 employees dedicated to advancing health through innovation. Specializing in human and animal healthcare, the company offers a range of products including biopharmaceuticals, contract manufacturing, and research services. Committed to improving lives worldwide, Boehringer Ingelheim's collaborative culture drives breakthroughs in pharmaceutical science.
Boehringer Ingelheim